Regulatory reports

Our regulatory reports provide legal and regulatory analysis for different countries and complex areas of the CBD industry. The majority of the reports focus on specific countries, providing a detailed overview of the regulatory landscape along with all current and possible future restrictions, definitions, as well as the relevant laws and governing bodies. In addition, we offer a number of other reports that analyse controversial and obscure areas and provide straightforward explanations along with our interpretation of the law.

Regulatory report: UK

Written by Marija Obradovic || 10th May 2021 || Regulatory reports |

This report offers an in-depth look at the current regulatory framework for hemp, CBD and cannabis in the UK, including its medical and recreational cannabis regime ...

Regulatory report: Slovakia

Written by Dmytro Korchahin || 28th April 2021 || Regulatory reports |

CBD will become legal for the first time in Slovakia on 1st May 2021. This report offers a detailed overview of the regulatory framework in the country for hemp, CBD and medical and recreational cannabis ...

Regulatory report: Denmark

Written by Lorenzo Guaragna || 13th April 2021 || Regulatory reports |

Cultivation of hemp with less than 0.2% THC is legal in Denmark. This report provides an overview of the country's regulatory framework for CBD, hemp and cannabis ...

Regulatory report: France

Written by Elsa Carrasco || 8th April 2021 || Regulatory reports |

The future regulation, and interpretation of existing rules, of cannabis in all its forms is a recurring subject in France. This report provides an overview of the current regulatory framework ...

Regulatory report: South Africa

Written by Marija Obradovic || 1st April 2021 || Regulatory reports |

This report covers the current regulatory regime for hemp, CBD and cannabis in South Africa, including the regimes for medical and recreational cannabis ...

Regulatory report: Switzerland

Written by Laura Garay Gómez || 29th March 2021 || Regulatory reports |

Switzerland is currently experiencing important changes in its cannabis regulation. This report details the current regulatory framework for hemp, CBD and cannabis, and provides information on forthcoming changes ...

Regulatory report: China

Written by Tao Hong || 26th March 2021 || Regulatory reports |

This report offers a regulatory overview of hemp and CBD in China, covering mainland China, as well as provincial regulations in Yunnan and Heilongjiang ...

Regulatory report: Poland

Written by Laura Garay Gómez || 19th March 2021 || Regulatory reports |

This report offers an overview of the current regulations in place for CBD and cannabis in Poland, including all aspects from cultivation and processing, to finished products, medical and recreational cannabis ...

Regulatory report: Netherlands

Written by Dmytro Korchahin || 15th February 2021 || Regulatory reports |

The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD ...

Regulatory report: Canada

Written by Anthony Traurig || 8th February 2021 || Regulatory reports |

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules ...

Regulatory report: Philippines

Written by Elsa Carrasco || 13th January 2021 || Regulatory reports |

A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the...

Regulatory report: North Macedonia

Written by CBD-Intel || 11th January 2021 || Regulatory reports |

Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework ...

Regulatory report: Cyprus

Written by CBD-Intel || 15th December 2020 || Regulatory reports |

CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place ...

Regulatory report: Ecuador

Written by Lenka Hajnovicova || 10th December 2020 || Regulatory reports |

This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis ...

Regulatory report: Ireland

Written by Elsa Carrasco || 9th December 2020 || Regulatory reports |

Cannabis, THC and CBN are controlled substances in Ireland under the Misuse of Drugs Act, but CBD and CBG are not. This report offers an overview of the current regime in Ireland ...

Regulatory report: Italy

Written by Lorenzo Guaragna || 16th November 2020 || Regulatory reports |

The Italian regulatory landscape differentiates between hemp and cannabis. This report offers a detailed overview of the current regime for CBD as well as for medical and recreational cannabis ...

Regulatory report: Greece

Written by Elsa Carrasco || 5th November 2020 || Regulatory reports |

There is currently no specific national legislation in Greece relating to CBD, nor are there any restrictions that could prohibit the sale and import of CBD isolates, provided that the CBD source complies with relevant laws ...

Regulatory report: Hungary

Written by Marija Obradovic || 27th October 2020 || Regulatory reports |

This report offers a comprehensive overview of the current regulations in place in Hungary for CBD and related products, including laws around medical and recreational cannabis ...

Regulatory report: Australia

Written by CBD-Intel || 15th October 2020 || Regulatory reports |

CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD ...

Regulatory report: Brazil

Written by Marija Obradovic || 6th October 2020 || Regulatory reports |

A recent proposal in Brazil could see the legalisation of hemp cultivation for industrial purposes and cannabis for medical use. This report provides an overview of the current regulatory framework ...

Regulatory report: Japan

Written by Lenka Hajnovicova || 17th September 2020 || Regulatory reports |

This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws ...

Regulatory report: Lithuania

Written by CBD-Intel || 4th August 2020 || Regulatory reports |

This regulatory report provides a detailed analysis of the current regulations in place in Lithuania, as well as discussing possible future legislation that could change the legal framework ...

Regulatory report: Russia

Written by CBD-Intel || 30th July 2020 || Regulatory reports |

Russia allows industrial hemp to be grown, but with limitations. This report provides an overview of the current regulatory regime in place for CBD and hemp in Russia ...

Regulatory report: Uruguay

Written by Lenka Hajnovicova || 15th July 2020 || Regulatory reports |

This report offers a comprehensive overview of the regulatory regime for CBD and cannabis in Uruguay, including rules around extracts, finished products, import/export and medicinal and recreation cannabis ...

Regulatory report: Ukraine

Written by CBD-Intel || 9th July 2020 || Regulatory reports |

The Ukrainian legal framework distinguishes between industrial hemp and cannabis. This report provides a clear analysis of the current regulatory framework for CBD and related products in Ukraine ...

Regulatory report: Romania

Written by Elsa Carrasco || 30th June 2020 || Regulatory reports |

Pure CBD is not a scheduled substance in Romania. This report examines the current regulatory framework for hemp and CBD in Romania, covering all aspects from import and export to medical and recreational cannabis ...

Regulatory report: Florida

Written by Berta Camps Bisbal || 15th June 2020 || Regulatory reports |

This report provides an up-to-date analysis of the current regulatory regime for CBD and hemp-related products in the US state of Florida ...

Regulatory report: Germany

Written by Lenka Hajnovicova || 8th June 2020 || Regulatory reports |

Medical cannabis is legal in Germany, where domestic cultivation is expected to begin in autumn 2020. This report covers Germany's regulatory regime for cannabis and CBD ...

Regulatory report: Jilin province, China

Written by CBD-Intel || 1st June 2020 || Regulatory reports |

Jilin province is the third province in China to be actively working on hemp regulation. This report offers an analysis on the potential upcoming regulations, looking at all aspects from imports to cultivation ...

Regulatory report: Hong Kong

Written by CBD-Intel || 19th May 2020 || Regulatory reports |

This report provides an overview of the current regulatory landscape for CBD and hemp in Hong Kong, including analysis of the restrictions relating to medical and recreational cannabis ...

Regulatory report: South Korea

Written by Marija Obradovic || 18th May 2020 || Regulatory reports |

This report offers our analysis of the regulatory regime in South Korea for CBD and related products, including extracts and finished products, their import and export, and medical and recreational cannabis ...

Regulatory report: Czech Republic

Written by Lenka Hajnovicova || 14th May 2020 || Regulatory reports |

This report offers a thorough overview of the current regulatory regime for CBD in the Czech Republic, covering all aspects from extracts and finished products to medical and recreational cannabis ...